| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |